Mount Yale Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Sell
4,166
-1,109
-21% -$431K 0.13% 139
2025
Q1
$2.29M Buy
5,275
+1,160
+28% +$505K 0.2% 108
2024
Q4
$1.52M Buy
4,115
+105
+3% +$38.7K 0.12% 149
2024
Q3
$2.09M Buy
4,010
+35
+0.9% +$18.2K 0.2% 115
2024
Q2
$2.15M Buy
3,975
+145
+4% +$78.6K 0.17% 118
2024
Q1
$1.99M Buy
3,830
+245
+7% +$127K 0.15% 135
2023
Q4
$1.69M Sell
3,585
-129
-3% -$60.8K 0.16% 138
2023
Q3
$1.62M Buy
3,714
+473
+15% +$206K 0.18% 128
2023
Q2
$1.44M Buy
3,241
+51
+2% +$22.7K 0.15% 142
2023
Q1
$1.47M Buy
3,190
+94
+3% +$43.2K 0.16% 132
2022
Q4
$1.59M Buy
3,096
+14
+0.5% +$7.18K 0.18% 126
2022
Q3
$1.4M Sell
3,082
-14
-0.5% -$6.36K 0.19% 119
2022
Q2
$1.49M Sell
3,096
-380
-11% -$183K 0.19% 120
2022
Q1
$1.71M Buy
3,476
+18
+0.5% +$8.85K 0.19% 123
2021
Q4
$1.6M Buy
3,458
+5
+0.1% +$2.32K 0.17% 133
2021
Q3
$1.29M Sell
3,453
-1,617
-32% -$603K 0.15% 155
2021
Q2
$1.94M Buy
5,070
+71
+1% +$27.1K 0.23% 94
2021
Q1
$1.79M Buy
4,999
+308
+7% +$111K 0.23% 94
2020
Q4
$1.51M Buy
4,691
+130
+3% +$41.7K 0.21% 106
2020
Q3
$1.23M Buy
4,561
+440
+11% +$118K 0.17% 124
2020
Q2
$1.08M Buy
4,121
+581
+16% +$153K 0.19% 118
2020
Q1
$804K Buy
3,540
+342
+11% +$77.7K 0.18% 124
2019
Q4
$848K Buy
3,198
+907
+40% +$241K 0.15% 131
2019
Q3
$650K Buy
2,291
+163
+8% +$46.2K 0.12% 151
2019
Q2
$610K Buy
2,128
+467
+28% +$134K 0.11% 151
2019
Q1
$477K Sell
1,661
-493
-23% -$142K 0.09% 182
2018
Q4
$651K Sell
2,154
-955
-31% -$289K 0.13% 142
2018
Q3
$901K Sell
3,109
-193
-6% -$55.9K 0.16% 120
2018
Q2
$786K Buy
3,302
+425
+15% +$101K 0.15% 127
2018
Q1
$632K Buy
+2,877
New +$632K 0.14% 140